{"pmid":32458502,"title":"Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in non-hospitalized COVID-19 patients.","text":["Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in non-hospitalized COVID-19 patients.","SARS-CoV-2 is highly infectious, and infection by this virus results in COVID-19, manifesting predominantly respiratory symptoms in the lower respiratory system. Detection of viral genomic materials by RT-PCR is the gold standard for diagnosis. Suspected COVID-19 patients who had a documented history of exposure and exhibited symptoms, but did not have positive PCR test results, were generally self-quarantined with prescriptions aiming to help attenuate their symptoms. These prescriptions are however neither specific nor highly effective for COVID-19 treatment. Given the rapidly growing pandemic and overwhelmed medical system, the number of self-quarantined patients is increasing. There is an urgent need of alternative medicine to help patients relieve symptoms during self-quarantine, and to potentially help increase their chances of survival and recovery from the infection. We report here a case of COVID-19 that never had a positive PCR test result during disease progression but was confirmed with antibody test post recovery. This patient was self-quarantined and received diammonium glycyrrhizinate, a steroid-like molecule, in combination with Vitamin C as alternative medicine. This patient went through severe COVID-19 but eventually recovered upon the implementation of this treatment regimen, suggesting potential therapeutic effects of diammonium glycyrrhizinate as alternative medicine to help relieve COVID-19 symptoms. This article is protected by copyright. All rights reserved.","J Med Virol","Ding, Hong","Deng, Wenjun","Ding, Lingling","Ye, Xiaoqun","Yin, Shanye","Huang, Weishan","32458502"],"abstract":["SARS-CoV-2 is highly infectious, and infection by this virus results in COVID-19, manifesting predominantly respiratory symptoms in the lower respiratory system. Detection of viral genomic materials by RT-PCR is the gold standard for diagnosis. Suspected COVID-19 patients who had a documented history of exposure and exhibited symptoms, but did not have positive PCR test results, were generally self-quarantined with prescriptions aiming to help attenuate their symptoms. These prescriptions are however neither specific nor highly effective for COVID-19 treatment. Given the rapidly growing pandemic and overwhelmed medical system, the number of self-quarantined patients is increasing. There is an urgent need of alternative medicine to help patients relieve symptoms during self-quarantine, and to potentially help increase their chances of survival and recovery from the infection. We report here a case of COVID-19 that never had a positive PCR test result during disease progression but was confirmed with antibody test post recovery. This patient was self-quarantined and received diammonium glycyrrhizinate, a steroid-like molecule, in combination with Vitamin C as alternative medicine. This patient went through severe COVID-19 but eventually recovered upon the implementation of this treatment regimen, suggesting potential therapeutic effects of diammonium glycyrrhizinate as alternative medicine to help relieve COVID-19 symptoms. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Ding, Hong","Deng, Wenjun","Ding, Lingling","Ye, Xiaoqun","Yin, Shanye","Huang, Weishan"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458502","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26064","keywords":["covid-19","pcr test negative","alternative medicine","antibody test positive","prolonged symptoms"],"topics":["Treatment"],"weight":1,"_version_":1668141322639245312,"score":9.490897,"similar":[{"pmid":32363011,"pmcid":"PMC7178815","title":"Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2.","text":["Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2.","COVID-19 is the most rapidly growing pandemic in modern time, and the need for serological testing is most urgent. Although the diagnostics of acute patients by RT-PCR is both efficient and specific, we are also crucially in need of serological tools for investigating antibody responses and assessing individual and potential herd immunity. We evaluated a commercially available test developed for rapid (within 15 minutes) detection of SARS-CoV-2-specific IgM and IgG by 29 PCR-confirmed COVID-19 cases and 124 negative controls. The results revealed a sensitivity of 69% and 93.1% for IgM and IgG, respectively, based solely on PCR-positivity due to the absence of a serological gold standard. The assay specificities were shown to be 100% for IgM and 99.2% for IgG. This indicates that the test is suitable for assessing previous virus exposure, although negative results may be unreliable during the first weeks after infection. More detailed studies on antibody responses during and post infection are urgently needed.","Infect Ecol Epidemiol","Hoffman, Tove","Nissen, Karolina","Krambrich, Janina","Ronnberg, Bengt","Akaberi, Dario","Esmaeilzadeh, Mouna","Salaneck, Erik","Lindahl, Johanna","Lundkvist, Ake","32363011"],"abstract":["COVID-19 is the most rapidly growing pandemic in modern time, and the need for serological testing is most urgent. Although the diagnostics of acute patients by RT-PCR is both efficient and specific, we are also crucially in need of serological tools for investigating antibody responses and assessing individual and potential herd immunity. We evaluated a commercially available test developed for rapid (within 15 minutes) detection of SARS-CoV-2-specific IgM and IgG by 29 PCR-confirmed COVID-19 cases and 124 negative controls. The results revealed a sensitivity of 69% and 93.1% for IgM and IgG, respectively, based solely on PCR-positivity due to the absence of a serological gold standard. The assay specificities were shown to be 100% for IgM and 99.2% for IgG. This indicates that the test is suitable for assessing previous virus exposure, although negative results may be unreliable during the first weeks after infection. More detailed studies on antibody responses during and post infection are urgently needed."],"journal":"Infect Ecol Epidemiol","authors":["Hoffman, Tove","Nissen, Karolina","Krambrich, Janina","Ronnberg, Bengt","Akaberi, Dario","Esmaeilzadeh, Mouna","Salaneck, Erik","Lindahl, Johanna","Lundkvist, Ake"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363011","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/20008686.2020.1754538","keywords":["covid-19","igg","igm","diagnostics","rapid test","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496024182784,"score":168.38329},{"pmid":32427924,"title":"Artificial intelligence-enabled rapid diagnosis of patients with COVID-19.","text":["Artificial intelligence-enabled rapid diagnosis of patients with COVID-19.","For diagnosis of coronavirus disease 2019 (COVID-19), a SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used. However, this test can take up to 2 d to complete, serial testing may be required to rule out the possibility of false negative results and there is currently a shortage of RT-PCR test kits, underscoring the urgent need for alternative methods for rapid and accurate diagnosis of patients with COVID-19. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as some patients may have normal radiological findings at early stages of the disease. In this study, we used artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history and laboratory testing to rapidly diagnose patients who are positive for COVID-19. Among a total of 905 patients tested by real-time RT-PCR assay and next-generation sequencing RT-PCR, 419 (46.3%) tested positive for SARS-CoV-2. In a test set of 279 patients, the AI system achieved an area under the curve of 0.92 and had equal sensitivity as compared to a senior thoracic radiologist. The AI system also improved the detection of patients who were positive for COVID-19 via RT-PCR who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients, whereas radiologists classified all of these patients as COVID-19 negative. When CT scans and associated clinical history are available, the proposed AI system can help to rapidly diagnose COVID-19 patients.","Nat Med","Mei, Xueyan","Lee, Hao-Chih","Diao, Kai-Yue","Huang, Mingqian","Lin, Bin","Liu, Chenyu","Xie, Zongyu","Ma, Yixuan","Robson, Philip M","Chung, Michael","Bernheim, Adam","Mani, Venkatesh","Calcagno, Claudia","Li, Kunwei","Li, Shaolin","Shan, Hong","Lv, Jian","Zhao, Tongtong","Xia, Junli","Long, Qihua","Steinberger, Sharon","Jacobi, Adam","Deyer, Timothy","Luksza, Marta","Liu, Fang","Little, Brent P","Fayad, Zahi A","Yang, Yang","32427924"],"abstract":["For diagnosis of coronavirus disease 2019 (COVID-19), a SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is routinely used. However, this test can take up to 2 d to complete, serial testing may be required to rule out the possibility of false negative results and there is currently a shortage of RT-PCR test kits, underscoring the urgent need for alternative methods for rapid and accurate diagnosis of patients with COVID-19. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value for ruling out SARS-CoV-2 infection, as some patients may have normal radiological findings at early stages of the disease. In this study, we used artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history and laboratory testing to rapidly diagnose patients who are positive for COVID-19. Among a total of 905 patients tested by real-time RT-PCR assay and next-generation sequencing RT-PCR, 419 (46.3%) tested positive for SARS-CoV-2. In a test set of 279 patients, the AI system achieved an area under the curve of 0.92 and had equal sensitivity as compared to a senior thoracic radiologist. The AI system also improved the detection of patients who were positive for COVID-19 via RT-PCR who presented with normal CT scans, correctly identifying 17 of 25 (68%) patients, whereas radiologists classified all of these patients as COVID-19 negative. When CT scans and associated clinical history are available, the proposed AI system can help to rapidly diagnose COVID-19 patients."],"journal":"Nat Med","authors":["Mei, Xueyan","Lee, Hao-Chih","Diao, Kai-Yue","Huang, Mingqian","Lin, Bin","Liu, Chenyu","Xie, Zongyu","Ma, Yixuan","Robson, Philip M","Chung, Michael","Bernheim, Adam","Mani, Venkatesh","Calcagno, Claudia","Li, Kunwei","Li, Shaolin","Shan, Hong","Lv, Jian","Zhao, Tongtong","Xia, Junli","Long, Qihua","Steinberger, Sharon","Jacobi, Adam","Deyer, Timothy","Luksza, Marta","Liu, Fang","Little, Brent P","Fayad, Zahi A","Yang, Yang"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427924","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1038/s41591-020-0931-3","locations":["thoracic"],"topics":["Diagnosis"],"weight":1,"_version_":1667352728836243456,"score":167.93758},{"pmid":32391676,"title":"[Follow-up testing of viral nucleic acid in discharged patients with moderate type of COVID-19].","text":["[Follow-up testing of viral nucleic acid in discharged patients with moderate type of COVID-19].","OBJECTIVE: To investigate the clinical outcome of patients with moderate type of coronavirus disease 2019 (COVID-19) after discharge by retesting viral nucleic acid. METHODS: Seven patients with moderate COVID-19 met the discharge criteria enacted by National Health Commission were quarantined in hospital for 7 days, then continuously quarantined at home for 4 weeks after discharged. During the quarantined period, the symptoms and signs were documented, and sputum or nasal swab and feces samples were collected to test SARS-CoV-2 nucleic acid by RT-PCR method. RESULTS: There was no symptoms and signs during the quarantine period in all 7 patients. However, respiratory swabs from 3 patients were confirmed positive of SARS-CoV-2 nucleic acid at 5 to 7 days after they met the discharge criteria. CONCLUSIONS: There is a relatively high incidence of positive viral nucleic acid in patients met the discharge criteria, and it is suggested that patients met the current discharge criteria should be quarantined in hospital for another 7 days and the follow-up viral testing is necessary.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Li, Youjiang","Hu, Yingying","Zhang, Xiaodong","Yu, Yuanyuan","Li, Bin","Wu, Jianguo","Wu, Yingping","Xia, Xiaoping","Xu, Jian","32391676"],"abstract":["OBJECTIVE: To investigate the clinical outcome of patients with moderate type of coronavirus disease 2019 (COVID-19) after discharge by retesting viral nucleic acid. METHODS: Seven patients with moderate COVID-19 met the discharge criteria enacted by National Health Commission were quarantined in hospital for 7 days, then continuously quarantined at home for 4 weeks after discharged. During the quarantined period, the symptoms and signs were documented, and sputum or nasal swab and feces samples were collected to test SARS-CoV-2 nucleic acid by RT-PCR method. RESULTS: There was no symptoms and signs during the quarantine period in all 7 patients. However, respiratory swabs from 3 patients were confirmed positive of SARS-CoV-2 nucleic acid at 5 to 7 days after they met the discharge criteria. CONCLUSIONS: There is a relatively high incidence of positive viral nucleic acid in patients met the discharge criteria, and it is suggested that patients met the current discharge criteria should be quarantined in hospital for another 7 days and the follow-up viral testing is necessary."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Li, Youjiang","Hu, Yingying","Zhang, Xiaodong","Yu, Yuanyuan","Li, Bin","Wu, Jianguo","Wu, Yingping","Xia, Xiaoping","Xu, Jian"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391676","source":"PubMed","week":"202020|May 11 - May 17","topics":["Diagnosis"],"weight":1,"_version_":1666528579984293888,"score":166.64816},{"pmid":32222122,"title":"[Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)].","text":["[Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)].","OBJECTIVE: To investigate the clinical outcome of patients with moderate type of corona virus disease 2019 (COVID-19) after discharge by retesting viral nucleic acid. METHODS: Seven patients with moderate COVID-19 met the discharge criteria enacted by National Health Commission were quarantine in hospital for 7 days, then continuously quarantined at home for 4 weeks after discharged. During the three weeks of quarantined period, the symptoms and signs were documented; and sputum or nasal swab and feces samples were collected to test SARS-COV-2 nucleic acid by RT-PCR method. RESULTS: There were no symptoms and signs during the quarantine period in all 7 patients. However, respiratory swabs from 3 patients were confirmed positive of SARS-COV-2 nucleic acid at 5 to 7 days after they met the discharge criteria. CONCLUSIONS: The study indicates that there is a relatively high incidence of positive viral nucleic acid in patients met the discharge criteria, and it is suggested that patients met the current discharge criteria should be quarantined in hospital for another 7 days and the follow-up viral testing is necessary.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Li, Youjiang","Hu, Yingying","Zhang, Xiaodong","Yu, Yuanyuan","Li, Bin","Wu, Jianguo","Wu, Yingping","Xia, Xiaoping","Xu, Jian","32222122"],"abstract":["OBJECTIVE: To investigate the clinical outcome of patients with moderate type of corona virus disease 2019 (COVID-19) after discharge by retesting viral nucleic acid. METHODS: Seven patients with moderate COVID-19 met the discharge criteria enacted by National Health Commission were quarantine in hospital for 7 days, then continuously quarantined at home for 4 weeks after discharged. During the three weeks of quarantined period, the symptoms and signs were documented; and sputum or nasal swab and feces samples were collected to test SARS-COV-2 nucleic acid by RT-PCR method. RESULTS: There were no symptoms and signs during the quarantine period in all 7 patients. However, respiratory swabs from 3 patients were confirmed positive of SARS-COV-2 nucleic acid at 5 to 7 days after they met the discharge criteria. CONCLUSIONS: The study indicates that there is a relatively high incidence of positive viral nucleic acid in patients met the discharge criteria, and it is suggested that patients met the current discharge criteria should be quarantined in hospital for another 7 days and the follow-up viral testing is necessary."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Li, Youjiang","Hu, Yingying","Zhang, Xiaodong","Yu, Yuanyuan","Li, Bin","Wu, Jianguo","Wu, Yingping","Xia, Xiaoping","Xu, Jian"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32222122","source":"PubMed","week":"202014|Mar 30 - Apr 05","topics":["Diagnosis"],"weight":1,"_version_":1666138492255600644,"score":166.18762},{"pmid":32442308,"title":"The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.","text":["The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.","BACKGROUND: COVID-19 is a global pandemic but the follow-up data of discharged patients was barely described. AIMS: To investigate clinical outcomes, distribution of quarantine locations, and the infection status of the contacts of COVID-19 patients after discharge. DESIGN: A prospective cohort study. METHODS: Demographics, baseline characteristics of 131 COVID-19 patients discharged from February 3 to 21, 2020 in Wuhan, China were collected and analyzed by reviewing the medical records retrospectively. Post-hospitalization data related to clinical outcomes, quarantine locations and close contact history were obtained by following up the patients every week up to 4 weeks. RESULTS: 53 (40.05%) patients on discharge had cough (29.01%), fatigue (7.63%), expectoration (6.11%), chest tightness (6.11%), dyspnea (3.82%), chest pain (3.05%), and palpitation (1.53%). These symptoms constantly declined in 4 weeks post discharge. Transient fever recurred in 11 (8.4%) patients. 78 (59.5%) discharged patients underwent chest CT and 2 (1.53%) showed deterioration. 94 (71.8%) patients received SARS-CoV-2 retest and 8 (6.10%) reported positive. 7 (2.29%) patients were re-admitted because of fever or positive SARS-CoV-2 retest. 121 (92.37%) and 4 (3.05%) patients were self-quarantined at home or community spots following discharge, with totally 167 closely contacted persons free of COVID-19 at the endpoint of study. CONCLUSIONS: The majority of COVID-19 patients after discharge were in the course of recovery. Readmission was required in rare cases due to suspected recurrence of COVID-19. Although no contacted infection observed, appropriate self-quarantine and regular reexamination are necessary, particularly for those who have recurred symptoms.","QJM","Wang, Xingyu","Xu, Hao","Jiang, Haini","Wang, Liuming","Lu, Chao","Wei, Xiang","Liu, Jihong","Xu, Shuyun","32442308"],"abstract":["BACKGROUND: COVID-19 is a global pandemic but the follow-up data of discharged patients was barely described. AIMS: To investigate clinical outcomes, distribution of quarantine locations, and the infection status of the contacts of COVID-19 patients after discharge. DESIGN: A prospective cohort study. METHODS: Demographics, baseline characteristics of 131 COVID-19 patients discharged from February 3 to 21, 2020 in Wuhan, China were collected and analyzed by reviewing the medical records retrospectively. Post-hospitalization data related to clinical outcomes, quarantine locations and close contact history were obtained by following up the patients every week up to 4 weeks. RESULTS: 53 (40.05%) patients on discharge had cough (29.01%), fatigue (7.63%), expectoration (6.11%), chest tightness (6.11%), dyspnea (3.82%), chest pain (3.05%), and palpitation (1.53%). These symptoms constantly declined in 4 weeks post discharge. Transient fever recurred in 11 (8.4%) patients. 78 (59.5%) discharged patients underwent chest CT and 2 (1.53%) showed deterioration. 94 (71.8%) patients received SARS-CoV-2 retest and 8 (6.10%) reported positive. 7 (2.29%) patients were re-admitted because of fever or positive SARS-CoV-2 retest. 121 (92.37%) and 4 (3.05%) patients were self-quarantined at home or community spots following discharge, with totally 167 closely contacted persons free of COVID-19 at the endpoint of study. CONCLUSIONS: The majority of COVID-19 patients after discharge were in the course of recovery. Readmission was required in rare cases due to suspected recurrence of COVID-19. Although no contacted infection observed, appropriate self-quarantine and regular reexamination are necessary, particularly for those who have recurred symptoms."],"journal":"QJM","authors":["Wang, Xingyu","Xu, Hao","Jiang, Haini","Wang, Liuming","Lu, Chao","Wei, Xiang","Liu, Jihong","Xu, Shuyun"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442308","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/qjmed/hcaa178","keywords":["covid-2019","discharged patients","follow-up","outcomes"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1667535119430189056,"score":161.11992}]}